Quantum Imaging is pleased to announce that it is changing its name to Creavo Medical Technologies Ltd (Creavo) in a move to better align its brand identity with its ambition as an innovative developer of medical technology for a range of global healthcare markets. The name change will take immediate effect.

Quantum Imaging has enjoyed a successful first six months of 2016. It has met many commercial milestones, including receiving ISO certification from the British Standards Institute, and award recognition in the fields of innovation and leadership.

The company has also grown significantly with recruitment across a range of specialist disciplines, including clinical and research. Such success has inevitably seen the company’s vision and values evolve to fully exploit the global opportunities for its ground-breaking diagnostic and detection technology. The name change reflects this wider thinking and provides room for further growth and development as the company moves closer to their commercialisation of its first piece of technology.

CEO of Creavo, Steve Parker said: “The first half of 2016 has been very positive for us andwe have achieved everything we set out to do to ensure that our technology becomes a reality. We are a forward-looking company and therefore wanted a brand identity that elevated us beyond the principles of quantum technology and reflected the real innovation and opportunity our finished products will deliver to global healthcare markets. We believe Creavo gives us this and we are excited to be moving in this direction.”

Creavo’s first product, VitalScan is set to receive a CE mark for European sale this autumn. This will be followed by a multi-centre clinical trial of up to 1,000 patients beginning before the end of 2016.